Valuation SMS Pharmaceuticals Limited

Stocks

Market Closed - NSE India S.E. 14:05:10 26/10/2026 +03			5-day change	1st Jan Change
417.85 ^INR	+0.78%		-7.25%	+34.62%

09-21	SMS Pharmaceuticals Limited(BSE:532815) added to S&P Global BMI Index	CI
08-01	SMS Pharmaceuticals Limited announces Annual dividend, payable on October 23, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	10,518	7,915	4,931	15,089	18,863	35,105
Change	-	-24.75%	-37.7%	206.01%	25.01%	86.1%
Enterprise Value (EV) ¹	12,660	10,082	7,398	17,536	21,556	38,296
Change	-	-20.36%	-26.62%	137.04%	22.93%	77.66%
P/E	16.8x	12.7x	-69.9x	30.3x	27.3x	33.6x
PBR	2.56x	1.68x	1.07x	2.81x	2.95x	4.47x
PEG	-	-25.87x	1x	-0x	0.8x	0.8x
Capitalization / Revenue	1.86x	1.52x	0.94x	2.13x	2.41x	3.95x
EV / Revenue	2.24x	1.94x	1.42x	2.47x	2.75x	4.31x
EV / EBITDA	10.3x	8.83x	13.7x	15x	15.5x	22.1x
EV / EBIT	12.5x	12.1x	32.5x	20.4x	20.5x	28.6x
EV / FCF	-12.4x	-44.8x	-23.4x	-70.3x	-31x	-41.1x
FCF Yield	-8.04%	-2.23%	-4.27%	-1.42%	-3.22%	-2.43%
Dividend per Share ²	0.3	0.3	0.3	0.4	0.4	0.4
Rate of return	0.24%	0.32%	0.52%	0.22%	0.19%	0.11%
EPS ²	7.386	7.35	-0.8339	5.886	7.799	11.15
Distribution rate	4.06%	4.08%	-36%	6.8%	5.13%	3.59%
Net sales ¹	5,651	5,199	5,221	7,093	7,827	8,886
EBITDA ¹	1,227	1,142	541.8	1,169	1,387	1,735
EBIT ¹	1,014	830.7	227.3	860.1	1,049	1,338
Net income ¹	625.3	622.2	-70.59	498.3	691.4	1,020
Net Debt ¹	2,142	2,167	2,467	2,447	2,693	3,191
Reference price ²	124.25	93.50	58.25	178.25	212.78	374.85
Nbr of stocks (in thousands)	84,652	84,652	84,652	84,652	88,652	93,652
Announcement Date	9/8/21 A	9/7/22 A	9/7/23 A	9/6/24 A	9/6/25 A	9/4/26 A

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SMS PHARMACEUTICALS LIMITED	-	-	-	-	409M
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.33x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.50x	7.04x	18.70x	2.12%	400.41B
Weighted average by Cap.	35.23x	8.29x	20.40x	1.8%